WO2001060922A1 - Process for the preparation of micronised collagen, and its therapeutic applications - Google Patents
Process for the preparation of micronised collagen, and its therapeutic applications Download PDFInfo
- Publication number
- WO2001060922A1 WO2001060922A1 PCT/EP2001/001283 EP0101283W WO0160922A1 WO 2001060922 A1 WO2001060922 A1 WO 2001060922A1 EP 0101283 W EP0101283 W EP 0101283W WO 0160922 A1 WO0160922 A1 WO 0160922A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- collagen
- micronised
- microns
- process according
- stream
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2389/00—Characterised by the use of proteins; Derivatives thereof
- C08J2389/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08J2389/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin
Definitions
- the present invention relates to a process for the preparation of powdered collagen starting from native collagen.
- Collagen a polypeptide substance having a molecular weight of approximately 130,000 daltons, is the most abundant fibrous protein in the higher vertebrates because it is the principal constituent of the skin, the connective tissue and the organic material present in the bones and teeth, and represents approximately one third of the total amount of proteins in the human body (Merck Index, Version 12:1, 2543, 1996).
- collagen in the bodies of mammals is preceded by the formation of a larger biosynthetic precursor, precollagen, which is then degraded by specific enzymes to form collagen.
- a larger biosynthetic precursor precollagen
- specific enzymes to form collagen.
- Various types of collagen occur naturally and they are all composed of three polypeptide chains which have a constant periodicity and which are arranged in a triple helix; the difference between the various types of collagen is caused by small differences in the primary structure of the chains.
- Type I collagen which is the basic constituent of the skin, bones and tendons, may be regarded as the most abundant of the various types of collagen; it has a 2 l (I) cc2 (I) chain composition where the two ⁇ l chains and the ⁇ 2 chain are homologous. Present between the two ⁇ l chains and the ⁇ 2 chain are electrostatic interactions and hydrogen bonds which, together with the presence of hydroxyproline, confer on the molecule characteristics of toughness and strength.
- the literature discloses the use of collagen as a stimulating agent in the process of wound-healing by interaction with various growth factors, for its action of capturing fibronectin, as well as the migration and replication of cells which are the consequence thereof (II collagene nella cicatrizzazione (Collagen in wound- healing) by B. Palmieri, published by Artestampa, January 1990, pages 40-42), and for other actions which have not yet been sufficiently clarified.
- collagen is currently used as a wound-healing agent in clinical surgery, in the treatment of burns, as a vehicle, in surgical prosthesis (suture threads, gauzes, etc.), as a material for implantation, or as a raw material of creams and ointments in the pharmaceutical and cosmetics sector (Beghe, Mian and Palmieri in Collageno e cicatrizzazione "Realt ⁇ e prospettive terapeu- tiche "(Collagen and wound-healing "Facts and therapeutic perspectives"), Istanbul, 1990; Mian & Mian, Topical collagen and wound Healing, 1992, supplement to vol.
- the collagen normally used in those sectors is type I collagen.
- Collagen is normally obtained in the stable and non-denatured form currently on the market by extraction and purification processes from animal organs, such as, for example, described in JP 2886164.
- the collagen so obtained is normally a gel which contains from 0.1 to 2.0% of collagen and which, in order then to be used in the various therapeutic applications indicated above, is normally subjected to further conversions; it is, for example, converted by lyophilisation into a platelet having a water content of approximately 17%, or, by drying, into a lamellar structure having a water content of approximately 20%.
- the powdered collagen currently on the market has, however, disadvantages and defects of not inconsiderable importance because it is available only in a coarse particle size (>500 microns) which does not enable it to adhere to moist surfaces and prevents it from being used in the form of a spray.
- the object of the present invention is therefore to obtain a product which, while maintaining the typical characteristics of collagen as regards its wound-healing activity, permits easy, simple and rapid application, is easy and practical to use, can be applied to areas of the body which are difficult of access (for example cavities and recesses), and is sterile and structurally homogeneous.
- the above has now been obtained by a particular micronisation process which constitutes one of the subjects of the present invention and which enables powdered collagen having a particle size of not more than 20 microns to be obtained.
- micronisation process utilises the normal atomisers currently on the market, such as the rotary cyclone atomisers produced by Niro A/S and described, for example, in United States patents US 5,632,100, US 5,615,493, US 4,490,403, US 4,369,091 and US 3,956,521, which are incorporated herein by reference.
- those atomisers basically comprise a cyclone structure where a solution of the product to be micronised is introduced through a rotating nozzle which brings about the nebulisation thereof and is struck by an ascending stream of an inert gas, generally air, heated to a temperature of the order of from 150 to 400°C.
- an inert gas generally air
- a 0.1 - 0.8% by weight/volume aqueous solution of collagen having a pH of from 3.0 to 6.0 is introduced into a normal atomiser and struck by a stream of gas having a temperature substantially lower than those used in the usual micronisation processes; the stream of inert gas, generally air, in fact has a temperature lower than 120°C, preferably of from 70 to 120°C, and even more preferably from 80 to 100°C.
- the aqueous collagen solution generally obtained by diluting a 1.0 - 2.0% by weight/volume gel of type I native collagen with slightly acidic water, preferably has a final pH of from 4 to 5 and a content of collagen of from 0.3 to 0.5% by weight/volume; the collagen powder is then preferably collected in a closed container which is in a form such that the powder maintains a moisture content of less than 15%.
- the product so obtained is a collagen powder having a particle size of from 5 to 30 microns, generally not more than 20 microns and preferably of approximately 18 microns, which maintains intact the quaternary aggregation form (in bundles of fibrils) typical of native collagen; the powder so obtained can then be divided up, sterilised and placed in suitable containers (spray dispensers, sachets, bottles, etc.) according to methods known in the art.
- the particle size of not more than 20 microns permits both optimum adhesion of the collagen to the wound surface and its use in metering systems in spray dispensers.
- This last aspect is a very important characteristic of the present invention because the spray formulation permits the production of "multidose" packaging which has the enormous advantage of permitting the discontinuous and repeated use of the product without altering its characteristics and sterility.
- the diluted gel is atomised in an atomiser operating under the following conditions:
- micronised collagen can then be packaged in the forms of administration known in the art, generally in combination with the normal excipients and coadju- vants; the preferred formulations are, for example, sachets of from 0.1 to 50 grams, bottles of from 0.5 to 250 grams, spray dispensers of from 10 to 1000 ml; in this last case it is of course necessary to add a suitable propellant gas, generally a preconstituted mixture of n-butane, isobutane and propane gases.
- a suitable propellant gas generally a preconstituted mixture of n-butane, isobutane and propane gases.
- 500 litres of a 1.2% by w/v collagen solution are diluted with 1500 litres of distilled water (dilution ratio 1 :4) in order to obtain 2000 litres at 0.4% by w/v.
- the pH of the solution is corrected to 4.5 ⁇ 0.5 using dilute acetic acid.
- the solution is then introduced into a test atomiser under the following operating conditions: air and nozzle temperature: 80-85°C temperature on entry: 80°C temperature on discharge: 65°C pressure of the nebuliser: 2 bar capacity of the feed pump: 40 1/hour.
- micronised collagen obtained in the manner described in Example 1 is packaged automatically in sachets of combined polyethylene/aluminium/paper material; using a dose of 0.1, 0.25, 0.5 and 1.0 gram per sachet.
- the sachets so obtained are subjected to treatment with ionising radiation at a dose of 25 kilograys in order to obtain a powder completely free from microorganisms.
- Example 3
- micronised collagen obtained in the manner described in Example 1 is packaged automatically in bottles of neutral glass having a cap and an under-cap of non-toxic plastics material; using doses of 1 , 2 and 5 grams per bottle.
- the bottles so obtained are subjected to treatment with ionising radiation at a dose of 25 kilograys in order to obtain a powder completely free from micro-organisms.
- Example 4
- micronised collagen obtained in the manner described in Example 1 is packaged automatically in aluminium spray dispensers having an internal lining of ep- oxy resin. 50 and 125 ml spray dispensers containing, respectively, 1 and 2 grams of micronised collagen are used. The spray dispensers are then equipped with delivery valves and the propellant composed of a preconstituted mixture of n-butane, isobutane and propane (95:2:3) is then introduced at a pressure of approximately 1.3 bar.
- the spray dispensers so obtained are subjected to treatment with ionising radiation at a dose of 25 kilograys in order to obtain a powder completely free from microorganisms.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT01915198T ATE296859T1 (en) | 2000-02-15 | 2001-02-07 | METHOD FOR PRODUCING MICRONIZED COLLAGEN, AND THERAPEUTIC USES |
EP01915198A EP1263884B1 (en) | 2000-02-15 | 2001-02-07 | Process for the preparation of micronised collagen, and its therapeutic applications |
CA002395709A CA2395709C (en) | 2000-02-15 | 2001-02-07 | Process for the preparation of micronised collagen, and its therapeutic applications |
DE60111192T DE60111192T2 (en) | 2000-02-15 | 2001-02-07 | METHOD FOR THE PRODUCTION OF MICRONIZED COLLAGEN, AND THERAPEUTIC USES |
JP2001560296A JP2003523438A (en) | 2000-02-15 | 2001-02-07 | Method for producing ultrafine collagen and its therapeutic application |
US11/747,765 US20070253912A1 (en) | 2000-02-15 | 2007-05-11 | Process for the preparation of micronised collagen, and its therapeutic applications |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2000MI000246A IT1317832B1 (en) | 2000-02-15 | 2000-02-15 | PROCEDURE FOR THE PREPARATION OF MICRONIZED COLLAGEN AND THERAPEUTIC APPLICATIONS. |
ITMI2000A000246 | 2000-02-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001060922A1 true WO2001060922A1 (en) | 2001-08-23 |
Family
ID=11444011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/001283 WO2001060922A1 (en) | 2000-02-15 | 2001-02-07 | Process for the preparation of micronised collagen, and its therapeutic applications |
Country Status (9)
Country | Link |
---|---|
US (2) | US20030012741A1 (en) |
EP (2) | EP1541634B1 (en) |
JP (1) | JP2003523438A (en) |
AT (1) | ATE296859T1 (en) |
CA (1) | CA2395709C (en) |
DE (2) | DE60136300D1 (en) |
ES (2) | ES2243465T3 (en) |
IT (1) | IT1317832B1 (en) |
WO (1) | WO2001060922A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014183770A1 (en) | 2013-05-15 | 2014-11-20 | Euroresearch S.R.L. | "collagen powder, composition and use" |
US20170233944A1 (en) * | 2016-02-15 | 2017-08-17 | Modern Meadow, Inc. | Biofabricated material containing collagen fibrils |
US11214844B2 (en) | 2017-11-13 | 2022-01-04 | Modern Meadow, Inc. | Biofabricated leather articles having zonal properties |
US11352497B2 (en) | 2019-01-17 | 2022-06-07 | Modern Meadow, Inc. | Layered collagen materials and methods of making the same |
US11913166B2 (en) | 2015-09-21 | 2024-02-27 | Modern Meadow, Inc. | Fiber reinforced tissue composites |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3805654B2 (en) * | 2001-08-29 | 2006-08-02 | 株式会社ネクスト | Fine particles of biopolymers that prevent hemostasis and adhesion |
US7923431B2 (en) | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
AU2003302906B2 (en) * | 2002-12-11 | 2009-04-02 | Ferrosan Medical Devices A/S | Gelatine-based materials as swabs |
AR054637A1 (en) * | 2004-01-30 | 2007-07-11 | Ferrosan As | AEROSOLS AND HEMOSTATIC COMPOSITIONS |
US8021684B2 (en) * | 2004-07-09 | 2011-09-20 | Ferrosan Medical Devices A/S | Haemostatic composition comprising hyaluronic acid |
US8642831B2 (en) * | 2008-02-29 | 2014-02-04 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
US8545855B2 (en) * | 2008-10-31 | 2013-10-01 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US20100111836A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Compositions and methods for therapeutic delivery with frozen particles |
US8721583B2 (en) * | 2008-10-31 | 2014-05-13 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8725420B2 (en) * | 2008-10-31 | 2014-05-13 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8762067B2 (en) | 2008-10-31 | 2014-06-24 | The Invention Science Fund I, Llc | Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data |
US8545856B2 (en) * | 2008-10-31 | 2013-10-01 | The Invention Science Fund I, Llc | Compositions and methods for delivery of frozen particle adhesives |
US20110150765A1 (en) * | 2008-10-31 | 2011-06-23 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Frozen compositions and methods for piercing a substrate |
US8603494B2 (en) * | 2008-10-31 | 2013-12-10 | The Invention Science Fund I, Llc | Compositions and methods for administering compartmentalized frozen particles |
US8731841B2 (en) * | 2008-10-31 | 2014-05-20 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8409376B2 (en) | 2008-10-31 | 2013-04-02 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8793075B2 (en) * | 2008-10-31 | 2014-07-29 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8849441B2 (en) * | 2008-10-31 | 2014-09-30 | The Invention Science Fund I, Llc | Systems, devices, and methods for making or administering frozen particles |
US8545857B2 (en) * | 2008-10-31 | 2013-10-01 | The Invention Science Fund I, Llc | Compositions and methods for administering compartmentalized frozen particles |
US9060934B2 (en) * | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US9072688B2 (en) | 2008-10-31 | 2015-07-07 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US9072799B2 (en) * | 2008-10-31 | 2015-07-07 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US20100111831A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Compositions and methods for surface abrasion with frozen particles |
US9050070B2 (en) * | 2008-10-31 | 2015-06-09 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8731840B2 (en) * | 2008-10-31 | 2014-05-20 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8603495B2 (en) * | 2008-10-31 | 2013-12-10 | The Invention Science Fund I, Llc | Compositions and methods for biological remodeling with frozen particle compositions |
US8551505B2 (en) * | 2008-10-31 | 2013-10-08 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US20100111857A1 (en) | 2008-10-31 | 2010-05-06 | Boyden Edward S | Compositions and methods for surface abrasion with frozen particles |
US9050317B2 (en) * | 2008-10-31 | 2015-06-09 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US20100111845A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Compositions and methods for therapeutic delivery with frozen particles |
US20100111835A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Compositions and methods for therapeutic delivery with frozen particles |
US8788211B2 (en) * | 2008-10-31 | 2014-07-22 | The Invention Science Fund I, Llc | Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition |
US8221480B2 (en) | 2008-10-31 | 2012-07-17 | The Invention Science Fund I, Llc | Compositions and methods for biological remodeling with frozen particle compositions |
US9060926B2 (en) | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US9060931B2 (en) * | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for delivery of frozen particle adhesives |
US20100178038A1 (en) * | 2009-01-12 | 2010-07-15 | Mediatek Inc. | Video player |
US20130011451A1 (en) * | 2011-07-06 | 2013-01-10 | Diversified Glogal Technologies, Llc | Footbed with non-denatured collagen |
BR112014010548A2 (en) * | 2011-10-31 | 2017-05-02 | Shell Int Research | process for preparing a micronized polymer and micronized polymer |
CA2865349C (en) | 2012-03-06 | 2021-07-06 | Ferrosan Medical Devices A/S | Pressurized container containing haemostatic paste |
EP2977066A3 (en) | 2012-06-12 | 2016-07-27 | Ferrosan Medical Devices A/S | Dry haemostatic composition |
BR112015030612B1 (en) | 2013-06-21 | 2020-07-21 | Ferrosan Medical Devices A/S | method for preparing a dry composition |
EP3470094B1 (en) | 2013-12-11 | 2020-07-22 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
CA2960309A1 (en) | 2014-10-13 | 2016-04-21 | Ferrosan Medical Devices A/S | Dry composition for use in haemostasis and wound healing |
RU2705905C2 (en) | 2014-12-24 | 2019-11-12 | Ферросан Медикал Дивайсиз А/С | Syringe for holding and mixing first and second substances |
EP3310391A4 (en) | 2015-06-19 | 2019-03-27 | Global Health Solutions, LLC | Petrolatum-based compositions comprising cationic biocides |
CN107771093B (en) | 2015-07-03 | 2021-06-15 | 弗罗桑医疗设备公司 | Syringe for mixing two components and for maintaining vacuum under storage conditions |
RU2020140481A (en) | 2017-09-12 | 2021-02-12 | Шилпа Медикеа Лимитед | TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASTY |
ES2968412T3 (en) | 2018-05-09 | 2024-05-09 | Ferrosan Medical Devices As | Method for preparing a hemostatic composition |
US20220323549A1 (en) * | 2019-09-12 | 2022-10-13 | Global Health Solutions, Inc. | Oil-based wound care compositions and methods |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2274458A (en) * | 1993-01-20 | 1994-07-27 | Laporte B S D Limited | Production of soluble collagen by hydrolysis and spray-drying |
JPH0827035A (en) * | 1994-07-18 | 1996-01-30 | Hokuyo Kk | New powder collagen and its production |
RO111787B1 (en) * | 1995-07-26 | 1997-01-30 | Gabriel Lucian Radu | Biotechnological process for the preparation of collagen hydrolysates |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2352894B2 (en) * | 1973-10-22 | 1981-04-16 | Aktieselskabet Niro Atomizer, Soeborg | Process for the production of powder from milk or similar liquids |
DK210679A (en) * | 1979-05-22 | 1980-11-23 | Niro Atomizer As | METHOD OF SPRAY DRYING A LIQUID PRODUCT AND SPRAY DRYER FOR USE IN EXERCISING THE PROCEDURE |
DE3314903A1 (en) * | 1982-04-28 | 1983-11-03 | Edward Julius Bromyard Herefordshire Bals | SPRAYING DEVICE |
DK157053B (en) * | 1982-06-14 | 1989-11-06 | Niro Atomizer As | PROCEDURE FOR THE PREPARATION OF AN AGGLOMERATED POWDER-MILK PRODUCT |
EP0239970A3 (en) * | 1986-03-31 | 1988-04-20 | Toa Nenryo Kogyo Kabushiki Kaisha | Assemblage of hydroxyl apatite particles and liquid chromatography column using the same |
IT1214505B (en) * | 1987-03-12 | 1990-01-18 | Gentili Ist Spa | PROCEDURE FOR THE PREPARATION OF COLLAGEN AND PRODUCTS SO OBTAINED. |
JP2789115B2 (en) * | 1989-09-07 | 1998-08-20 | 株式会社高研 | Process for producing granular pharmaceutical sustained-release agent using soluble collagen powder as carrier |
US5196185A (en) * | 1989-09-11 | 1993-03-23 | Micro-Collagen Pharmaceutics, Ltd. | Collagen-based wound dressing and method for applying same |
DE69325595T2 (en) * | 1993-11-17 | 2000-03-16 | Niro Holding A/S | METHOD AND SPRAY DRYING DEVICE FOR PRODUCING AGGLOMERED POWDER |
US5615493A (en) * | 1994-03-11 | 1997-04-01 | Niro Holding A/S/ | Spray drying device |
DE4414755C2 (en) * | 1994-04-27 | 2000-11-16 | Lohmann Therapie Syst Lts | Collagen preparation for the controlled delivery of active ingredients, processes and use |
-
2000
- 2000-02-15 IT IT2000MI000246A patent/IT1317832B1/en active
-
2001
- 2001-02-07 DE DE60136300T patent/DE60136300D1/en not_active Expired - Lifetime
- 2001-02-07 ES ES01915198T patent/ES2243465T3/en not_active Expired - Lifetime
- 2001-02-07 EP EP05101795A patent/EP1541634B1/en not_active Expired - Lifetime
- 2001-02-07 DE DE60111192T patent/DE60111192T2/en not_active Expired - Lifetime
- 2001-02-07 US US10/169,857 patent/US20030012741A1/en not_active Abandoned
- 2001-02-07 EP EP01915198A patent/EP1263884B1/en not_active Expired - Lifetime
- 2001-02-07 CA CA002395709A patent/CA2395709C/en not_active Expired - Lifetime
- 2001-02-07 WO PCT/EP2001/001283 patent/WO2001060922A1/en active IP Right Grant
- 2001-02-07 AT AT01915198T patent/ATE296859T1/en not_active IP Right Cessation
- 2001-02-07 JP JP2001560296A patent/JP2003523438A/en not_active Withdrawn
- 2001-02-07 ES ES05101795T patent/ES2313210T3/en not_active Expired - Lifetime
-
2007
- 2007-05-11 US US11/747,765 patent/US20070253912A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2274458A (en) * | 1993-01-20 | 1994-07-27 | Laporte B S D Limited | Production of soluble collagen by hydrolysis and spray-drying |
JPH0827035A (en) * | 1994-07-18 | 1996-01-30 | Hokuyo Kk | New powder collagen and its production |
RO111787B1 (en) * | 1995-07-26 | 1997-01-30 | Gabriel Lucian Radu | Biotechnological process for the preparation of collagen hydrolysates |
Non-Patent Citations (4)
Title |
---|
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLOMBUS, OHIO, US; DESELNICU MIHAI ET AL.: "Hygroscopic collagen powder", XP002167737, retrieved from STN Database accession no. 93:9574 * |
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLOMBUS, OHIO, US; GOTO KOICHI ET AL.: "Powdered collagen and its manufacture", XP002167734, retrieved from STN Database accession no. 124:292849 * |
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLOMBUS, OHIO, US; RADU GABRIEL LUCIAN, CALOIANU MARIA, BOBE GHEORGHE: "Biotechnological process for the preparation of collagen hydrolysates in soln. or powder form", XP002167736, retrieved from STN Database accession no. 133:32026 * |
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLOMBUS, OHIO, US; TRANDAFIR VIORICA, CONSTANTINESCU MARIA: "Collagen powder used in cosmetics", XP002167735, retrieved from STN Database accession no. 95:171918 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014183770A1 (en) | 2013-05-15 | 2014-11-20 | Euroresearch S.R.L. | "collagen powder, composition and use" |
US11913166B2 (en) | 2015-09-21 | 2024-02-27 | Modern Meadow, Inc. | Fiber reinforced tissue composites |
US20170233944A1 (en) * | 2016-02-15 | 2017-08-17 | Modern Meadow, Inc. | Biofabricated material containing collagen fibrils |
US11001679B2 (en) | 2016-02-15 | 2021-05-11 | Modern Meadow, Inc. | Biofabricated material containing collagen fibrils |
US11286354B2 (en) | 2016-02-15 | 2022-03-29 | Modern Meadow, Inc. | Method for making a biofabricated material containing collagen fibrils |
US11525042B2 (en) | 2016-02-15 | 2022-12-13 | Modern Meadow, Inc. | Composite biofabricated material |
US11530304B2 (en) * | 2016-02-15 | 2022-12-20 | Modern Meadow, Inc. | Biofabricated material containing collagen fibrils |
US11542374B2 (en) * | 2016-02-15 | 2023-01-03 | Modern Meadow, Inc. | Composite biofabricated material |
US11214844B2 (en) | 2017-11-13 | 2022-01-04 | Modern Meadow, Inc. | Biofabricated leather articles having zonal properties |
US11352497B2 (en) | 2019-01-17 | 2022-06-07 | Modern Meadow, Inc. | Layered collagen materials and methods of making the same |
Also Published As
Publication number | Publication date |
---|---|
DE60136300D1 (en) | 2008-12-04 |
DE60111192D1 (en) | 2005-07-07 |
ES2243465T3 (en) | 2005-12-01 |
EP1541634B1 (en) | 2008-10-22 |
JP2003523438A (en) | 2003-08-05 |
US20030012741A1 (en) | 2003-01-16 |
ATE296859T1 (en) | 2005-06-15 |
EP1263884B1 (en) | 2005-06-01 |
CA2395709C (en) | 2009-09-22 |
DE60111192T2 (en) | 2006-04-27 |
IT1317832B1 (en) | 2003-07-15 |
US20070253912A1 (en) | 2007-11-01 |
EP1263884A1 (en) | 2002-12-11 |
EP1541634A1 (en) | 2005-06-15 |
ES2313210T3 (en) | 2009-03-01 |
ITMI20000246A0 (en) | 2000-02-15 |
CA2395709A1 (en) | 2001-08-23 |
ITMI20000246A1 (en) | 2001-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1263884B1 (en) | Process for the preparation of micronised collagen, and its therapeutic applications | |
JP4741726B2 (en) | Formulation for applying anti-inflammatory agent, especially disinfectant and / or wound healing promoter to upper respiratory tract and / or ear | |
AU2011260260B2 (en) | Process for making dry and stable hemostatic compositions | |
EP2997077B1 (en) | Collagen powder, composition and use | |
JPH02196728A (en) | Dispensing method for active substance pharmaceutically or therapeutically | |
JPH02504163A (en) | cross-linked carboxypolysaccharide | |
US20080070993A1 (en) | Additives for cosmetic products and the like | |
ITPD930165A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE BASED ON HYALURONIC ACID AND ITS DERIVATIVES | |
CN107670097A (en) | A kind of oligopeptide Wound dressing for promoting diabetes wound healing and preparation method thereof | |
US20230081677A1 (en) | Patch product based on natural polymers | |
US5466669A (en) | Immunostimulatory agent | |
CN101347388A (en) | Oral cavity nursing agent and preparation technique thereof | |
KR100687781B1 (en) | Preparations for the application of anti-inflammatory agents | |
JP2903182B2 (en) | Collagen, its production method and cosmetics | |
EP0619115A1 (en) | Container comprising a metered dose valve and microparticles of a drug for topical treatment of skin disorders | |
CN114181295B (en) | Polypeptide derivative and application thereof, hydrogel and preparation method thereof | |
US7829072B2 (en) | Serum albumin compositions for use in cleansing or dermatological products for skin or hair | |
CN113304055A (en) | Dentin desensitizing paste with bionic remineralization repairing effect and preparation process thereof | |
JP2010195714A (en) | Pharmaceutical composition for wound healing | |
CN110023325B (en) | Fibronectin derived peptides with increased biological activity and reduced susceptibility to neutrophil elastase degradation | |
US20230310538A1 (en) | Tissue repair and wound healing composition and method using low molecular weight hydrolyzed collagen | |
US20240207351A1 (en) | Tissue repair and wound healing composition and method using low molecular weight hydrolyzed collagen | |
TW201247950A (en) | Solubilized collagen fiber and method for producing the same | |
IT202100018647A1 (en) | Collagen powder, process for its preparation and its uses. | |
HU203981B (en) | Process for producing pharmaceutical compositions assisting healing of wounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): BR CA JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001915198 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2395709 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10169857 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 560296 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 2001915198 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001915198 Country of ref document: EP |